DLGAP1-AS4

Across TCGA pan-cancer cohorts, DLGAP1-AS4 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated DLGAP1-AS4 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher DLGAP1-AS4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DLGAP1-AS4 expression acts as an unfavorable survival marker, although some lineages such as BRCA and PAAD show a favorable association.

LUAD, READ, and HNSC are the cancer types where DLGAP1-AS4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.166	0.388	.001	78	view →
READ	DFS	Tertile	III,IV	0.335	0.797	<.001	72	view →
HNSC	OS	Tertile	All	0.406	0.681	<.001	70	view →
DLBC	DFS	Tertile	III,IV	0.111	0.775	<.001	69	view →
UVM	DFS	Tertile	All	0.240	0.780	.003	54	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
UCEC	DFS	Tertile	All	0.428	0.690	.020	36	view →
BRCA	OS	Tertile	All	0.745	0.528	.014	24	view →
ACC	OS	Tertile	All	0.147	0.685	.018	21	view →
PAAD	OS	Tertile	II,III,IV	1.000	0.403	.013	18	view →
THCA	DFS	Tertile	III,IV	0.682	0.840	.024	18	view →
KIRC	OS	Tertile	All	0.489	0.658	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

DLGAP1-AS4–LUAD (DFS)

Open the LUAD breakdown →